Anika Therapeutics (ANIK) news
Recent news
Anika Therapeutics Inc: B. Riley raises target price to $21 from $18
AInvest Wire · Jul 30, 2026Anika Therapeutics - enters fifth amendment to credit agreement on July 10, 2026 - SEC filing
Anika Therapeutics, Inc. has executed the fifth amendment to its credit agreement, as disclosed in a recent SEC filing [1]. The amendment, dated July 10, 2026, modifies certain terms of the company’s existing credit facility. While the specific terms of the amendment were not fully detailed in the…
AInvest Wire · Jul 14, 2026Anik Industries - buys 50% stake in Best Season Developers LLP for 404.7 mln rupees
AInvest Wire · Jun 17, 2026Open Lending to be acquired by ANV for $3.15/shr
Open Lending Corporation (Nasdaq: LPRO) has announced that it has entered into a definitive agreement to be acquired by ANV, a special purpose acquisition company (SPAC), at a price of $3.15 per share. The transaction marks a significant development for the company, which provides lending…
AInvest Wire · Jun 16, 2026Maxland Berhad - Co and Sinora enter settlement agreement with GSR, Transkripsi, and Anika on June 9, 2026
On June 9, 2026, Maxland Berhad and Sinora have entered into a settlement agreement with GSR, Transkripsi, and Anika. The terms of the agreement remain undisclosed, but the resolution is expected to address ongoing legal or financial matters involving the parties. This development follows recent…
AInvest Wire · Jun 9, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.